StackItSmart Authoritative Cycle Generator

Evidence-Based Harm Reduction for Clinical Research

Version 2.0 • Clinical Research Platform • Educational Simulation Only

Safety-First Design

  • Conservative dosing protocols
  • Comprehensive guardrails
  • Risk-tier mapping (0-10 scale)
  • Mandatory medical supervision

Clinical Evidence

  • Single-compound beginners
  • Testosterone base required
  • No 19-nors for beginners
  • Laboratory monitoring protocols

Educational Focus

  • Harm reduction education
  • Clinical research contexts
  • Transparent methodology
  • JSON export capability

Non-Negotiable Safety Principles

Cycle Design

  • • Never labeled as "Safe" - Risk Tiers only
  • • Single-compound starts preferred
  • • No 19-nors for beginners
  • • No hepatotoxic orals for risk factors

PCT Protocol

  • • Single SERM by default
  • • No SERM stacking
  • • AI only if triggered by labs/symptoms
  • • Never zero out estradiol

Contraindications

  • • Age under 25 years
  • • Cardiovascular risk factors
  • • Liver disease history
  • • Anxiety/depression conditions

Monitoring

  • • Baseline labs required
  • • Mid-cycle monitoring
  • • Post-PCT assessment
  • • Emergency discontinuation triggers

Intended Audience & Use Cases

Clinical Researchers

  • • Harm reduction studies
  • • Safety protocol development
  • • Educational material creation
  • • Risk assessment modeling

Healthcare Providers

  • • Patient education tools
  • • Risk communication
  • • Monitoring protocol guidance
  • • Clinical decision support

Educational Institutions

  • • Pharmacology education
  • • Endocrinology training
  • • Risk analysis studies
  • • Public health research

🚨 CRITICAL MEDICAL DISCLAIMERS

⚠️ NOT MEDICAL ADVICE: This is an educational simulation only. Results are not medical recommendations.

🏥 MANDATORY MEDICAL SUPERVISION: Consult qualified healthcare providers before, during, and after any PED use.

📋 BLOODWORK REQUIRED: Comprehensive laboratory monitoring is essential for safety.

⚖️ LEGAL COMPLIANCE: Verify legality in your jurisdiction. Many compounds are controlled substances.

🎯 RESEARCH PURPOSE: This tool is for harm reduction education in clinical research contexts.

StackItSmart Authoritative Cycle Generator v2

Evidence-based harm reduction for clinical research contexts

Technical Implementation Details

Risk Tier Mapping (Deterministic)

Low
Score: 0-2
Low-Moderate
Score: 3-5
Moderate
Score: 6-7
Moderate-High
Score: 8
High
Score: 9-10

PCT Timing Calculations

  • • Test E/C: Start PCT 14±2 days after last injection
  • • Test Prop: Start PCT 3-5 days after last injection
  • • Half-life basis: ~3 half-lives for clearance

Compound Selection Logic

  • • Beginners: Testosterone enanthate/cypionate only
  • • Dose range: 180-300 mg/week (anchor: 200-240 mg/week)
  • • Injection frequency: 2x/week minimum for stable levels
  • • Cycle length: 8-10 weeks for beginners